Clinical data acquisition

How To Accelerate & Improve the Quality of CDISC SDTM Deliverables: Design with the End in Mind, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, November 17, 2022
Quality, Clinical data acquisition, Clinical Data Interchange Standards Consortium, Data collection, Safety, FDA, Global Partnership on Artificial Intelligence, SDTM, Acceleration, NCI, Risk, Food, CDISC, Medical device, Pharmaceutical industry, Risk management

TORONTO, Nov. 17, 2022 /PRNewswire-PRWeb/ -- Since the FDA passed regulations requiring submitted datasets to be compliant with the CDISC Study Data Tabulation Model (SDTM), clinical trial sponsors have faced a dilemma. Should they design electronic case report forms (eCRFs) in line with SDTM from the outset? Or should they retrospectively convert data to CDISC SDTM at the end?

Key Points: 
  • The featured speakers will discuss the benefits of aligning with the Clinical Data Interchange Standards Consortium (CDISC) from study design.
  • The speakers will discuss how technology enables earlier Study Data Tabulation Model (SDTM) conversions and faster access to data.
  • Will it be possible to retrofit datasets and terminology into the CDISC SDTM and NCI Controlled Terminology models?
  • For more information, or to register for this event, visit How To Accelerate & Improve the Quality of CDISC SDTM Deliverables: Design with the End in Mind .